Intelligence · Patents
Patents expiring in 2043
Annual patent cliff calendar for 2043 — US pharmaceutical patents by expiration date.
- Patents
- 1,718
Quick answer
1,718 indexed pharmaceutical patents have expiration dates in 2043. Browse by soonest expiry with links to assignee companies and related drugs.
-
KR 20230116805
가도테리돌 제조를 위한 제조 방법
granted -
US 11718665
Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins
granted -
US 11717480
Extracellular vesicles and methods and uses thereof
granted -
US 11718647
Virus-like particles and methods of use
granted -
US 11717576
Antibody-immune agonist conjugate and applications thereof
granted -
US 11718616
JAK kinase inhibitor compounds for treatment of respiratory disease
granted -
US 11718655
Masked interleukin-12 polypeptides
granted -
US 11718613
N-(phenylsulfonyl)benzamides and related compounds as Bcl-2 inhibitors
granted -
US 11718621
Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use
granted -
US 11718658
T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and methods of use thereof
granted -
US 11717547
Compositions and methods for the treatment of autosomal recessive congenital ichthyosis
granted -
US 11717573
Methods and compositions for the treatment of cancer
granted -
US 11718612
Inhibitors of receptor interacting protein kinase I for the treatment of disease
granted -
US 11718679
CD137 antibodies and PD-1 antagonists and uses thereof
granted -
US 11718610
Compounds containing benzosultam
granted -
US 11718834
Compositions and methods for producing recombinant AAV
granted -
US 11718852
Non-liposomal systems for nucleic acid delivery
granted -
US 11718591
Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2- methylpentanoic acid and uses thereof
granted -
US 11718589
Compositions and methods of modulating short-chain dehydrogenase
granted -
US 11718576
Compositions and methods comprising resveratrol
granted -
US 11718530
Allotrope of carbon having increased electron delocalization
granted -
US 11718596
Amyloid targeting agents and methods of using the same
granted -
US 11717558
Nucleic acid molecules encoding activin receptor type IIA variants
granted -
US 11717542
Using tumor-navigating Salmonella to modulate tumor metabolism
granted -
US 11717565
Recombinant BCG overexpressing phoP-phoR
granted -
US 11718618
Substituted pyrido[2,1-a]isoquinolines as VMAT2 inhibitors
granted -
US 11718641
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
granted -
US 11717553
Combined plant extract for getting rid of mites and acne and preparation method and use thereof
granted -
US 11718630
Compositions and methods for treating cancer
granted -
CA 3235923
PROCEDES DE SYNTHESE A GRANDE ECHELLE DE COMPLEXES DE RADIONUCLEIDES
granted -
US 11723949
Modulators of complement activity
granted -
US 11723952
Methods and compositions for treating Huntington's Disease
granted -
US 11723982
Methods of treating an ocular disease or disorder
granted -
US 11723992
Method for extraction and purification of 68GA
granted -
US 11725248
Evaluation of mantle cell lymphoma and methods related thereto
granted -
US 11725024
Antibody drug conjugates
granted -
US 11725209
TMPRSS6 iRNA compositions and methods of use thereof
granted -
US 11725208
Conjugated antisense compounds and their use
granted -
US 11723881
Fortified CBD oil for treatment of PTSD
granted -
US 11723961
Maspin, maspin derivatives, and maspin mimetics for reducing ROS, inflammation, and skin aging
granted -
US 11723873
Oral dosage form of ticagrelor and preparation method thereof
granted -
US 11723903
Treatment of schizophrenia
granted -
US 11723362
Broad-spectrum synergistic antimicrobial compositions
granted -
US 11723864
Antimicrobial and anti-inflammatory compositions
granted -
US 11723929
Methods of improving cell-based therapy
granted -
US 11725008
Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferases
granted -
US 11723762
LIDAR based 3-D imaging with far-field illumination overlap
granted -
US 11723885
Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse
granted
Frequently asked questions
How many pharma patents expire in 2043?
1,718 published patents in our USPTO index have expiration dates falling in calendar year 2043.